Anouck Lamoureux

80 Avenue Augustin Fliche, Montpellier Cedex 5
Montpellier, 34295, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case series.

Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case series.

Journal: Cancer immunology, immunotherapy : CII

Published: September 07, 2025

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.

Journal: Acta dermato-venereologica

Published: August 06, 2024

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.

Journal: Alimentary pharmacology & therapeutics

Published: June 18, 2024

Prolonged complete remission of a lymphoepithelioma-like carcinoma of the skin with bone metastases induced by pembrolizumab.

Prolonged complete remission of a lymphoepithelioma-like carcinoma of the skin with bone metastases induced by pembrolizumab.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 25, 2024

Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.

Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.

Journal: Melanoma research

Published: March 28, 2024

Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Journal: The oncologist

Published: September 20, 2023

Radiation therapy on lentigo maligna: A single-centre retrospective study on 91 patients.

Radiation therapy on lentigo maligna: A single-centre retrospective study on 91 patients.

Journal: Annales de dermatologie et de venereologie

Published: August 23, 2023

Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature.

Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature.

Journal: Clinics and research in hepatology and gastroenterology

Published: July 26, 2023

« Malignant » Rosacea as a sign of systemic marginal zone lymphoma.

« Malignant » Rosacea as a sign of systemic marginal zone lymphoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 05, 2017

A first case of erythema multiforme-like contact dermatitis caused by propolis.

A first case of erythema multiforme-like contact dermatitis caused by propolis.

Journal: Contact dermatitis

Published: February 07, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026